Bioassays - a shoerter path to drug development

Disease-specific stem cells

Sydney IVF media suite

New Huntington disease collaboration with the University of Ediburgh
Collaboration between Sydney IVF and APAF to study early stages of Huntingtons disease
Sydney IVF derives FSHD-specific hESC line to aid drug discovery
First Australian licence for SCNT awarded to Sydney IVF
Sydney IVF and ASCC receive collaborative government grant
...more news...
Sydney IVF Home Page
 
  • Home
  • About Us
    • Our staff
    • Our mission
    • Our product
    • The Sydney IVF difference
    • Ethical governance
    • Scientific governance
    • Our stem cells
  • Stem Cells
    • Derivation of hESC
    • Characterization of hESC
    • Uses for hESC
    • Glossary
  • Our Product Pipeline
    • Stem cell platform
      • ESC derivation
      • Diseased hESC
      • ES media development
      • hESC culturing platform
      • Somatic Cell Nuclear Transfer (SCNT)
    • Bioassay platform
      • Differentiation
      • hESC-based assays for drug development
      • Automation
      • High content analysis
  • Partnering & Support
    • Individual partnered projects
    • Government funding
    • Future partnering
  • Egg & Embryo Donation
  • IP Portfolio
  • News & Events
    • News
    • Sydney IVF publications
  • Contact
Sydney IVF has ISO accreditation
  • Sitemap
  • Privacy
  • Contact Us
  • Glossary

Login